# Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit

> **NCT01878643** · EARLY_PHASE1 · COMPLETED · sponsor: **Stony Brook University** · enrollment: 47 (actual)

## Conditions studied

- Respiratory Infection
- Bacterial Resistance
- Respiratory Failure

## Interventions

- **DRUG:** vancomycin or gentamicin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01878643
- **Lead sponsor:** Stony Brook University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** 2002-12
- **Final completion:** 2002-12
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2013-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01878643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01878643, "Reduction of Bacterial Resistance With Inhaled Antibiotics in the Intensive Care Unit". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01878643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*